[
  {
    "nctId": "NCT04881760",
    "title": "A Phase 2 Study of Once-Weekly LY3437943 Compared With Placebo in Participants Who Have Obesity or Are Overweight With Weight-Related Comorbidities",
    "briefTitle": "A Study of LY3437943 in Participants Who Have Obesity or Are Overweight",
    "status": "COMPLETED",
    "startDate": "2021-05-20",
    "completionDate": "2022-11-22",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "LY3437943",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Overweight"
    ]
  },
  {
    "nctId": "NCT05829460",
    "title": "Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
    "briefTitle": "Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia",
    "status": "RECRUITING",
    "startDate": "2025-04-30",
    "completionDate": "2032-04-30",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Semaglutide",
      "Placebo",
      "LNG-IUD (Progestin)"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Endometrial Hyperplasia"
    ]
  },
  {
    "nctId": "NCT02404376",
    "title": "COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial",
    "briefTitle": "COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial",
    "status": "COMPLETED",
    "startDate": "2016-03",
    "completionDate": "2020-06",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Exenatide",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "ST Elevation Acute Myocardial Infarction"
    ]
  },
  {
    "nctId": "NCT01161394",
    "title": "Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study",
    "briefTitle": "Effect of Pioglitazone on Oxidative Load, Inflammatory End-Points and Vascular Reactivity in Obese Non-Diabetic Patients: A Dose Ranging Study",
    "status": "COMPLETED",
    "startDate": "",
    "completionDate": "2003-10",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Pioglitazone 15mg",
      "pioglitazone 30mg",
      "placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Inflammation"
    ]
  },
  {
    "nctId": "NCT03479476",
    "title": "A Double-Blind, Placebo-Controlled Trial of Metformin in Individuals With Fragile X Syndrome",
    "briefTitle": "A Trial of Metformin in Individuals With Fragile X Syndrome",
    "status": "COMPLETED",
    "startDate": "2018-04-30",
    "completionDate": "2024-05-22",
    "phases": [
      "PHASE2",
      "PHASE3"
    ],
    "interventions": [
      "Placebo Medication",
      "Metformin"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Fragile X Syndrome",
      "Fragile X Mental Retardation Syndrome",
      "Mental Retardation, X Linked",
      "Genetic Diseases, X-Linked",
      "Trinucleotide Repeat Expansion",
      "Fra(X) Syndrome",
      "Intellectual Disability",
      "FXS",
      "Neurobehavioral Manifestations",
      "Sex Chromosome Disorders"
    ]
  },
  {
    "nctId": "NCT05636176",
    "title": "Effects of Ziltivekimab Versus Placebo on Morbidity and Mortality in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Systemic Inflammation",
    "briefTitle": "A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation",
    "status": "RECRUITING",
    "startDate": "2023-05-08",
    "completionDate": "2027-07-02",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Ziltivekimab",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Heart Failure"
    ]
  },
  {
    "nctId": "NCT03287960",
    "title": "An Open Label, 1-Year Trial, Including a Double-Blind Placebo-Controlled Withdrawal Period, of Setmelanotide (RM-493), a Melanocortin 4 Receptor (MC4R) Agonist, in Leptin Receptor (LEPR) Deficiency Obesity Due to Bi-Allelic Loss-of-Function LEPR Genetic Mutation",
    "briefTitle": "Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity",
    "status": "COMPLETED",
    "startDate": "2018-01-30",
    "completionDate": "2020-09-25",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Setmelanotide",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Leptin Receptor Deficiency Obesity"
    ]
  },
  {
    "nctId": "NCT01811160",
    "title": "Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics",
    "briefTitle": "Metabolic Effects of Melatonin in Patients Treated With Second Generation Antipsychotics",
    "status": "COMPLETED",
    "startDate": "2008-10",
    "completionDate": "2011-11",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Melatonin",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Second Generation Antipsychotic Induced Metabolic Adverse Effects"
    ]
  },
  {
    "nctId": "NCT06863376",
    "title": "Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients",
    "briefTitle": "Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients",
    "status": "RECRUITING",
    "startDate": "2025-03-01",
    "completionDate": "2026-04-20",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Carbocysteine 375 MG"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Non-Alcoholic Fatty Liver Disease"
    ]
  },
  {
    "nctId": "NCT01766960",
    "title": "Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease.",
    "briefTitle": "Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver Disease",
    "status": "COMPLETED",
    "startDate": "2012-11",
    "completionDate": "2014-06",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "Morphine"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Fatty Liver"
    ]
  },
  {
    "nctId": "NCT03378960",
    "title": "Bioavailability Study of Omeprazole (20 mg) at Steady State (Multiple Dose) in Patients Who Have Undergone Bariatric Surgery",
    "briefTitle": "Study to Compare the Bioavailability of Omeprazole 20 mg Before and After Undergoing Surgery for Morbid Obesity",
    "status": "COMPLETED",
    "startDate": "2014-10-31",
    "completionDate": "2016-02-29",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Omeprazole 20mg"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Bariatric Surgery Candidate"
    ]
  },
  {
    "nctId": "NCT00231660",
    "title": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and Safety of Topiramate in the Treatment of Obese, Type 2 Diabetic Patients Treated With Metformin",
    "briefTitle": "A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With Metformin",
    "status": "COMPLETED",
    "startDate": "2000-10",
    "completionDate": "2002-06",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "topiramate"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Diabetes Mellitus, Type 2",
      "Diabetes Mellitus, Adult-Onset"
    ]
  },
  {
    "nctId": "NCT03961360",
    "title": "Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida: An Open Label, Comparative Effectiveness, Randomized Controlled Trial (ASPREO Trial)",
    "briefTitle": "Effectiveness of Higher Aspirin Dosing for Prevention of Preeclampsia in High Risk Obese Gravida",
    "status": "COMPLETED",
    "startDate": "2019-05-06",
    "completionDate": "2023-04-10",
    "phases": [
      "PHASE2",
      "PHASE3"
    ],
    "interventions": [
      "Aspirin 81 mg",
      "Aspirin 162 mg"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Pre-Eclampsia",
      "Hypertension in Pregnancy",
      "Obesity"
    ]
  },
  {
    "nctId": "NCT00806260",
    "title": "A Phase 2, Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Psychomotor Effect of VI-0521 in Healthy Overweight and Obese Subjects.",
    "briefTitle": "A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects.",
    "status": "COMPLETED",
    "startDate": "2008-12",
    "completionDate": "2009-05",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "VI-0521",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Overweight",
      "Obesity"
    ]
  },
  {
    "nctId": "NCT02621060",
    "title": "Effect of the Administration of Chlorogenic Acid on Glucemic Control, Insulin Secretion and Insulin Sensitivity in Patients With Impaired Glucose Tolerance",
    "briefTitle": "Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance",
    "status": "COMPLETED",
    "startDate": "2015-09",
    "completionDate": "2016-02",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Placebo",
      "Chlorogenic acid"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Impaired Glucose Tolerance"
    ]
  },
  {
    "nctId": "NCT00152360",
    "title": "The Effect of Xenical on Weight, Risk Factors and Burden of Medication",
    "briefTitle": "The Effect of Xenical on Weight and Risk Factors",
    "status": "COMPLETED",
    "startDate": "2005-06",
    "completionDate": "2013-03",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Orlistat"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Heart Diseases"
    ]
  },
  {
    "nctId": "NCT02325960",
    "title": "A Comparison of Exenatide and Insulin Glargine on Glycemic Variability in T2DM Patients Inadequately Controlled With Metformin Monotherapy",
    "briefTitle": "A Comparison of Exenatide and Insulin Glargine",
    "status": "COMPLETED",
    "startDate": "2015-01",
    "completionDate": "2016-10",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "exenatide",
      "Insulin glargine"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes"
    ]
  },
  {
    "nctId": "NCT04775082",
    "title": "Effect and Safety of Liraglutide 3.0 mg on Weight Management in Children With Obesity Aged 6 to Below 12 Years: 56-week, Double-blind, Randomised, Placebo-controlled Trial",
    "briefTitle": "SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity",
    "status": "ACTIVE_NOT_RECRUITING",
    "startDate": "2021-03-04",
    "completionDate": "2027-01-15",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Liraglutide",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity"
    ]
  },
  {
    "nctId": "NCT00585182",
    "title": "Venous Thromboembolism Prevention in the Morbidly Obese Medically Ill Patient: A Pharmacological Analysis of the Predictability of Prophylactic Weight-Based Enoxaparin Dosing.",
    "briefTitle": "Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT",
    "status": "COMPLETED",
    "startDate": "2007-01",
    "completionDate": "2008-04",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Enoxaparin 0.5 mg/kg once daily"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Venous Thrombosis",
      "Anticoagulants"
    ]
  },
  {
    "nctId": "NCT01270620",
    "title": "Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement: A Pilot Assessment of Short-term and Long-term Differences in Outcome",
    "briefTitle": "Desflurane or Propofol Anesthesia in Elderly Obese Patients Undergoing Total Knee Replacement",
    "status": "COMPLETED",
    "startDate": "2010-12",
    "completionDate": "2015-07",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "propofol",
      "Desflurane"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Arthritis"
    ]
  },
  {
    "nctId": "NCT04043520",
    "title": "Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women - 2018",
    "briefTitle": "Bioenergetic Effects of Aging and Menopause (BEAM)",
    "status": "RECRUITING",
    "startDate": "2019-09-24",
    "completionDate": "2024-08-31",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "GnRH antagonist",
      "Estrogen Product",
      "Placebo estradiol",
      "Placebo GnRH antagonist"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Menopause",
      "Obesity, Abdominal",
      "Aging",
      "Weight Gain"
    ]
  },
  {
    "nctId": "NCT01911520",
    "title": "Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients.",
    "briefTitle": "Dose Finding Study for Effective Reversal of a Deep Rocuronium-induced Neuromuscular Block With Sugammadex in Morbidly Obese Patients",
    "status": "COMPLETED",
    "startDate": "2011-01",
    "completionDate": "2012-06",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Sugammadex 2 mg/kg",
      "Sugammadex. 4 mg/kg"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Morbidly Obese Patients"
    ]
  },
  {
    "nctId": "NCT02452320",
    "title": "Prospective, Double Blind, Placebo Control, Study of Acetaminophen iv on Hospital Length of Stay in Morbidly Obese Individuals Undergoing Elective Laparoscopic Sleeve Gastrectomy",
    "briefTitle": "Prospective, Double Blind, Placebo Control, Bariatric IV Ace",
    "status": "COMPLETED",
    "startDate": "2016-02",
    "completionDate": "2017-01",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "intravenous acetaminophen",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity"
    ]
  },
  {
    "nctId": "NCT01921582",
    "title": "A Randomized Comparison of Osmotic Release Oral System Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Obese Patients With Binge Eating Disorder",
    "briefTitle": "A Comparison of Methylphenidate and Cognitive Behavioural Therapy for the Treatment of Binge Eating Disorder",
    "status": "COMPLETED",
    "startDate": "2013-08",
    "completionDate": "2015-09",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Methylphenidate"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Binge-Eating Disorder"
    ]
  },
  {
    "nctId": "NCT00994682",
    "title": "Long-term Role of Pioglitazone in Non-Alcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes Mellitus (T2DM).",
    "briefTitle": "University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial)",
    "status": "COMPLETED",
    "startDate": "2008-12",
    "completionDate": "2014-12",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Pioglitazone study drug",
      "Placebo",
      "Pioglitazone Open Label"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Nonalcoholic Steatohepatitis",
      "Nonalcoholic Fatty Liver Disease",
      "Type 2 Diabetes Mellitus"
    ]
  },
  {
    "nctId": "NCT05729282",
    "title": "Role of Hyperinsulinemia in Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis: Diazoxide Pilot & Feasibility Study",
    "briefTitle": "Glycemic Effect of Diazoxide in NAFLD",
    "status": "RECRUITING",
    "startDate": "2023-08-01",
    "completionDate": "2025-10",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "Diazoxide oral suspension, 1 mg per kg per dose",
      "Diazoxide oral suspension, 2 mg per kg per dose",
      "Placebo",
      "Deuterated water (2H2O/D2O)"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Hyperinsulinemia",
      "Insulin Resistance",
      "Non-Alcoholic Fatty Liver Disease",
      "Prediabetic State"
    ]
  },
  {
    "nctId": "NCT04551482",
    "title": "Oxytocin as a Neuroendocrine Therapy for Obesity in Youth",
    "briefTitle": "Oxytocin for Weight Loss in Adolescents",
    "status": "RECRUITING",
    "startDate": "2021-07-28",
    "completionDate": "2027-03-31",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Oxytocin nasal spray",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity, Adolescent",
      "Oxytocin"
    ]
  },
  {
    "nctId": "NCT01920282",
    "title": "Effect of Nebivolol and Lifestyle Modification on Large Artery Stiffness in Middle-Aged and Older Hypertensive Adults",
    "briefTitle": "Nebivolol, Lifestyle Modification and Arterial Stiffness",
    "status": "COMPLETED",
    "startDate": "2010-01",
    "completionDate": "2012-08",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Nebivolol"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Hypertension"
    ]
  },
  {
    "nctId": "NCT00845182",
    "title": "Effect of Pioglitazone With and Without Exenatide on Body Weight, Fat Topography, Beta Cell Function, and Glycemic Control in Type 2 Diabetic Patients",
    "briefTitle": "Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function",
    "status": "COMPLETED",
    "startDate": "2007-06",
    "completionDate": "2010-07",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Pioglitazone",
      "Exenatide",
      "Pioglitazone and Exenatide"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes",
      "Healthy",
      "Impaired Glucose Tolerance"
    ]
  },
  {
    "nctId": "NCT06264882",
    "title": "Cardiometabolic Consequences of the Loss of Ovarian Function",
    "briefTitle": "Cardiometabolic Consequences of the Loss of Ovarian Function",
    "status": "RECRUITING",
    "startDate": "2024-06-01",
    "completionDate": "2028-08-31",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Degarelix",
      "Transdermal Estradiol Patch",
      "Transdermal Placebo Patch"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Menopause",
      "Estrogen Deficiency",
      "Aging",
      "Adiposity"
    ]
  },
  {
    "nctId": "NCT06534320",
    "title": "A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Effects of Food in Single/Multiple Oral Administration of DA-302168S Tablets",
    "briefTitle": "Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets",
    "status": "COMPLETED",
    "startDate": "2024-04-18",
    "completionDate": "2024-12-31",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "DA-302168S",
      "Placebo of DA-302168S",
      "DA-302168S",
      "Placebo of DA-302168S"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Overweight and Obesity"
    ]
  },
  {
    "nctId": "NCT03642873",
    "title": "A Study Designed to Examine the Potential for a Drug-drug Interaction Between Guaifenesin and Hydrocodone Bitartrate in Normal Healthy Volunteers",
    "briefTitle": "Study to Evaluate Drug-drug Interactions of Guaifenesin and Hydrocodone Bitartrate",
    "status": "COMPLETED",
    "startDate": "2007-05-05",
    "completionDate": "2007-05-21",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "Humibid\u00ae",
      "Hydrocodone Bitartrate",
      "Humibid\u00ae and Hydrocodone Bitartrate tablet"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Healthy Subjects"
    ]
  },
  {
    "nctId": "NCT00504673",
    "title": "Comparison of the Effect of Insulin Detemir Versus Insulin NPH Both With Insulin Aspart on Weight Change in Overweight and Obese Subjects With Type 2 Diabetes",
    "briefTitle": "Comparison of Insulin Detemir Versus Insulin NPH on Weight Change in Overweight and Obese With Type 2 Diabetes",
    "status": "COMPLETED",
    "startDate": "2005-04",
    "completionDate": "2006-12",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "insulin detemir",
      "insulin NPH",
      "insulin aspart"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Diabetes",
      "Diabetes Mellitus, Type 2"
    ]
  },
  {
    "nctId": "NCT06739473",
    "title": "Total-body Glucose Utilization in Obesity",
    "briefTitle": "Total-body Glucose Utilization in Obesity",
    "status": "RECRUITING",
    "startDate": "2023-01-25",
    "completionDate": "2024-12",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Hyperinsulinemic euglycemic clamp",
      "CEUS or Contrast enhanced Ultrasound"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity and Overweight"
    ]
  },
  {
    "nctId": "NCT03052673",
    "title": "Per-operative Low-Dose Ketamine For Postoperative Pain Relief In Patients Undergoing Bariatric Surgery: A Randomised Study",
    "briefTitle": "Ketamine for Pain Relief in Bariatric Surgery",
    "status": "COMPLETED",
    "startDate": "2017-02-20",
    "completionDate": "2018-07-30",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Fentanyl",
      "ketamine"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Postoperative Pain"
    ]
  },
  {
    "nctId": "NCT05737927",
    "title": "Pharmacodynamics and Pharmacokinetics of Different Coated and Uncoated Formulations of Glucose Beads After Single and Multiple Dose Administration Under Fasting Conditions in Obese Healthy Subjects",
    "briefTitle": "Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects",
    "status": "COMPLETED",
    "startDate": "2020-09-16",
    "completionDate": "2020-11-09",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "Glucose 8 g coated beads (47% w/w)",
      "Glucose 12 g coated beads (47% w/w)",
      "Glucose 16 g coated beads (47% w/w)",
      "Glucose 12 g uncoated beads",
      "Glucose 12 g coated beads (60% w/w)",
      "Glucose 12 g coated beads (47% w/w)"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obese"
    ]
  },
  {
    "nctId": "NCT04166773",
    "title": "A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)",
    "briefTitle": "A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)",
    "status": "COMPLETED",
    "startDate": "2019-11-19",
    "completionDate": "2024-01-10",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Tirzepatide",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Nonalcoholic Steatohepatitis"
    ]
  },
  {
    "nctId": "NCT02804373",
    "title": "Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome",
    "briefTitle": "Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome",
    "status": "COMPLETED",
    "startDate": "2014-06",
    "completionDate": "2019-06-18",
    "phases": [
      "PHASE2",
      "PHASE3"
    ],
    "interventions": [
      "Oxytocin (OXT) continuous",
      "Placebo",
      "Placebo continuous",
      "Oxytocin"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Prader-Willi Syndrome"
    ]
  },
  {
    "nctId": "NCT02288273",
    "title": "A Randomized Double-blind, Parallel-group Study to Evaluate the Effect of BYDUREON Compared With Placebo on 24-hour Glucose Control in Metformin-treated Patients With Type 2 Diabetes",
    "briefTitle": "Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.",
    "status": "COMPLETED",
    "startDate": "2014-12",
    "completionDate": "2015-08",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Bydureon",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes"
    ]
  },
  {
    "nctId": "NCT05409027",
    "title": "A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62",
    "briefTitle": "A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62",
    "status": "COMPLETED",
    "startDate": "2021-07-23",
    "completionDate": "2024-02-07",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "SPI-62",
      "Cortisone-d8"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes Mellitus in Obese",
      "Obesity",
      "Type2Diabetes"
    ]
  },
  {
    "nctId": "NCT02629627",
    "title": "Effect of the Administration of Conjugated Linoleic Acid / Leucine Plus Metformin on Visceral Fat in Patients With Metabolic Syndrome",
    "briefTitle": "Conjugated Linoleic Acid / Leucine Versus Metformin on Visceral Fat in Metabolic Syndrome",
    "status": "COMPLETED",
    "startDate": "2016-03",
    "completionDate": "2017-10",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Metformin"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Metabolic Syndrome"
    ]
  },
  {
    "nctId": "NCT03714373",
    "title": "An Open-Label, Long-Term Safety and Efficacy Evaluation of Diazoxide Choline Extended-Release Tablets in Participants With Prader-Willi Syndrome With a Double-Blind, Placebo-Controlled, Randomized Withdrawal Period",
    "briefTitle": "Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period",
    "status": "COMPLETED",
    "startDate": "2018-10-01",
    "completionDate": "2023-08-17",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "DCCR",
      "DCCR",
      "Placebo for DCCR"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Prader-Willi Syndrome"
    ]
  },
  {
    "nctId": "NCT05264727",
    "title": "Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion",
    "briefTitle": "Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion",
    "status": "RECRUITING",
    "startDate": "2023-05-30",
    "completionDate": "2025-12-31",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Dextrose",
      "Clinisol 15%"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Healthy",
      "Type 2 Diabetes",
      "Obesity"
    ]
  },
  {
    "nctId": "NCT05042973",
    "title": "Empagliflozin to Elderly and Obese Patients With Cardiovascular Disease (Empire Prevent: Metabolic): A Randomized Controlled Trial",
    "briefTitle": "The Metabolic Effects of Empagliflozin in Patients With High Risk of Heart Failure",
    "status": "COMPLETED",
    "startDate": "2021-09-02",
    "completionDate": "2025-01-23",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Empagliflozin 10 MG",
      "Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity",
      "Heart Failure"
    ]
  },
  {
    "nctId": "NCT00892073",
    "title": "Combined Diazoxide and Metformin Therapy in Children With Hypothalamic Obesity Secondary to Craniopharyngioma: A Pilot Study",
    "briefTitle": "Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy",
    "status": "COMPLETED",
    "startDate": "2006-05",
    "completionDate": "2008-01",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Diazoxide",
      "Metformin"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Hypothalamic Obesity"
    ]
  },
  {
    "nctId": "NCT00707031",
    "title": "A Randomized, Open-label, Active-controlled, 2-arm Parallel-group, Multicenter 24-week Study Followed by an Extension Assessing the Efficacy and Safety of AVE0010 Versus Exenatide on Top of Metformin in Patients With Type 2 Diabetes Not Adequately Controlled With Metformin",
    "briefTitle": "GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin",
    "status": "COMPLETED",
    "startDate": "2008-06",
    "completionDate": "2010-11",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Lixisenatide (AVE0010)",
      "Exenatide",
      "Metformin"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Diabetes Mellitus, Type 2"
    ]
  },
  {
    "nctId": "NCT06568731",
    "title": "A PHASE 1, OPEN- LABEL STUDY TO EVALUATE THE MULTIPLE DOSE PHARMACOKINETICS OF DANUGLIPRON FOLLOWING ORAL ADMINISTRATION IN OTHERWISE HEALTHY ADULT PARTICIPANTS WITH OVERWEIGHT OR OBESITY",
    "briefTitle": "A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherwise Healthy Adults With Overweight or Obesity",
    "status": "COMPLETED",
    "startDate": "2024-08-23",
    "completionDate": "2024-12-18",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "Danuglipron"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Obesity"
    ]
  },
  {
    "nctId": "NCT01931982",
    "title": "Effect of GLP-1 on Microvascular Myocardial Function in Patients With Type 2",
    "briefTitle": "Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.",
    "status": "COMPLETED",
    "startDate": "2013-05",
    "completionDate": "2014-04",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Victoza"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes",
      "Microvascular Dysfunction"
    ]
  },
  {
    "nctId": "NCT00148382",
    "title": "Randomized, Double Blind, Parallel Group, Repeat Dose Pharmacokinetic and Pharmacodynamic Study of Four Doses of ATL-962 (40mg, 80mg, 120mg 240mg) in Otherwise-Healthy Obese Volunteers",
    "briefTitle": "Study of the Blood Levels and Effects of ATL-962 on Fat Excretion in Obese Subjects",
    "status": "COMPLETED",
    "startDate": "2005-04",
    "completionDate": "2005-07",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "ATL-962"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Obesity"
    ]
  },
  {
    "nctId": "NCT01298882",
    "title": "Effect of Diacerein on Insulin Secretion in Patients With Type 2 Diabetes Mellitus and Overweight or Obesity",
    "briefTitle": "Diacerein on Insulin Secretion in Diabetes",
    "status": "COMPLETED",
    "startDate": "",
    "completionDate": "",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Diacerein"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes Mellitus",
      "Overweight",
      "Obesity"
    ]
  },
  {
    "nctId": "NCT02432976",
    "title": "Impact of Intravenous Exenatide Versus Insulin on Quality of Life in Cardiac Surgery Patients: an Ancillary Study of the ExSTRESS Phase II/III Clinical Trial",
    "briefTitle": "Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients",
    "status": "COMPLETED",
    "startDate": "2015-05",
    "completionDate": "2017-01",
    "phases": [
      "PHASE2",
      "PHASE3"
    ],
    "interventions": [
      "Exenatide",
      "Insulin"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Quality of Life"
    ]
  },
  {
    "nctId": "NCT03361176",
    "title": "A Randomized, Double-blind, Dose-ranging Trial of Subcutaneous Sodium Deoxycholate Injections With or Without Low Dose Triamcinolone and Low Dose Lidocaine for Reduction of Submental Fat With Reduction of Pain and Swelling",
    "briefTitle": "Kybella With Triamcinolone",
    "status": "COMPLETED",
    "startDate": "2018-03-26",
    "completionDate": "2018-12-18",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Injectable sodium deoxycholate"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Adiposity"
    ]
  },
  {
    "nctId": "NCT02431676",
    "title": "Trial of Behavioral Weight Loss and Metformin Treatment to Lower Insulin Growth Factor in Cancer Survivors",
    "briefTitle": "Survivorship Promotion In Reducing IGF-1 Trial",
    "status": "COMPLETED",
    "startDate": "2015-05",
    "completionDate": "2018-12",
    "phases": [
      "PHASE2"
    ],
    "interventions": [
      "Metformin"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Breast Cancer",
      "Prostate Cancer",
      "Lung Cancer",
      "Colon Cancer",
      "Melanoma of Skin",
      "Endometrial Cancer",
      "Liver Cancer",
      "Pancreatic Cancer",
      "Rectal Cancer",
      "Kidney Cancer",
      "Other Solid Malignant Tumors"
    ]
  },
  {
    "nctId": "NCT05890976",
    "title": "Efficacy and Safety of Oral Semaglutide 50 mg Once Daily in Chinese Adults With Overweight or Obesity (OASIS 3)",
    "briefTitle": "Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in Chinese Adults Who Are Above a Healthy Weight Range (OASIS 3)",
    "status": "COMPLETED",
    "startDate": "2023-05-30",
    "completionDate": "2025-01-16",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Semaglutide",
      "Semaglutide Placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Overweight",
      "Obesity"
    ]
  },
  {
    "nctId": "NCT02455076",
    "title": "Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta\u00ae) Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes",
    "briefTitle": "Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta\u00ae) Therapy for the Inpatient Management of Patients With Type 2 Diabetes",
    "status": "COMPLETED",
    "startDate": "2015-09",
    "completionDate": "2018-03",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Exenatide",
      "Glargine",
      "Rapid-acting insulin analogs"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Type 2 Diabetes"
    ]
  },
  {
    "nctId": "NCT02300376",
    "title": "Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium, With a Limited Sampling Strategy for the Calculation of Glomerular Filtration Rate (GFR) and Validity Assessment Compared to the Renal Clearance of Inulin : DFGBay",
    "briefTitle": "Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin",
    "status": "COMPLETED",
    "startDate": "2014-12",
    "completionDate": "2017-12",
    "phases": [
      "PHASE3"
    ],
    "interventions": [
      "Dosage of Calcium edetate de sodium"
    ],
    "interventionTypes": [
      "DRUG"
    ],
    "conditions": [
      "Kidney Disease"
    ]
  },
  {
    "nctId": "NCT03141476",
    "title": "Perioperative Cefuroxime in Obese Patients: Dosage According to the BMI",
    "briefTitle": "Adequacy of Perioperative Cefuroxime Dosage According to the BMI",
    "status": "COMPLETED",
    "startDate": "2017-03-01",
    "completionDate": "2017-12-12",
    "phases": [
      "PHASE4"
    ],
    "interventions": [
      "Cefuroxime 1,5g",
      "Cefuroxime 3g",
      "Cefuroxime 4,5g"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Obesity; Drug"
    ]
  },
  {
    "nctId": "NCT02302976",
    "title": "GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration",
    "briefTitle": "GLP-1 Agonism for Blocking Cocaine Euphoria and Self-Administration",
    "status": "COMPLETED",
    "startDate": "2014-11",
    "completionDate": "2018-08-01",
    "phases": [
      "PHASE1"
    ],
    "interventions": [
      "cocaine hydrochloride",
      "exenatide",
      "placebo"
    ],
    "interventionTypes": [
      "DRUG",
      "DRUG",
      "DRUG"
    ],
    "conditions": [
      "Cocaine Dependence"
    ]
  }
]